Edwards Lifesciences (EW) executive logs 282-share tax withholding on Form 4

Rhea-AI Filing Summary

Edwards Lifesciences Corp executive Daveen Chopra reported a routine tax-related share disposition. On the transaction date, 282 shares of common stock were withheld at $83.98 per share to cover tax obligations, leaving Chopra with 31,919 shares of Edwards Lifesciences common stock held directly after the transaction.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Chopra Daveen

Role CVP, TMTT & Surgical

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock	282	$83.98	$24K

Holdings After Transaction: Common Stock — 31,919 shares (Direct, null)

Footnotes (1)

Key Figures

Tax-withholding shares: 282 shares Tax-withholding price: $83.98 per share Shares held after transaction: 31,919 shares

3 metrics

Tax-withholding shares 282 shares Shares withheld to cover tax obligations

Tax-withholding price $83.98 per share Valuation used for withheld shares

Shares held after transaction 31,919 shares Direct holdings after tax-withholding disposition

Key Terms

tax-withholding disposition, Common Stock, Form 4

3 terms

tax-withholding disposition financial

"transaction_action: "tax-withholding disposition""

A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.

Common Stock financial

"security_title: "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Form 4 regulatory

"INSIDER FILING DATA (Form 4)"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Chopra Daveen

(Last) (First) (Middle)

ONE EDWARDS WAY

(Street)

IRVINE CALIFORNIA 92614

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Edwards Lifesciences Corp [ EW ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CVP, TMTT & Surgical

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/03/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/03/2026		F		282	D	$83.98	31,919	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.

	Linda J. Park, Attorney-in-Fact	05/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Edwards Lifesciences (EW) executive Daveen Chopra report on this Form 4?

Daveen Chopra reported a tax-withholding disposition of 282 shares of Edwards Lifesciences common stock. The shares were withheld to satisfy tax obligations, rather than sold in the open market, and are recorded as a routine administrative transaction for compensation-related equity.

How many Edwards Lifesciences (EW) shares were withheld for taxes in this filing?

The filing shows 282 shares of Edwards Lifesciences common stock were withheld. This disposition is coded as a tax-withholding event, meaning the company retained these shares to cover tax liabilities tied to equity compensation, not as a discretionary open-market sale by the executive.

At what price were the Edwards Lifesciences (EW) shares valued for this tax-withholding event?

The 282 shares involved in the tax-withholding disposition were valued at $83.98 per share. This price is used to determine the value of shares withheld to satisfy the executive’s tax obligations associated with equity compensation in Edwards Lifesciences common stock.

How many Edwards Lifesciences (EW) shares does Daveen Chopra hold after this Form 4 transaction?

Following the tax-withholding disposition, Daveen Chopra directly holds 31,919 shares of Edwards Lifesciences common stock. This post-transaction figure shows his remaining equity position after accounting for the 282 shares withheld to cover related tax liabilities.

Does this Edwards Lifesciences (EW) Form 4 indicate an open-market sale by Daveen Chopra?

No, the transaction is classified as a tax-withholding disposition, not an open-market sale. Shares were retained by the company to pay tax liabilities linked to equity compensation, making this a routine administrative event rather than a discretionary buy or sell decision.